Mirae Asset Global Investments
BOLD

Mirae Asset Global Investments’s Audentes Therapeutics, Inc BOLD Stock Holding History

Mirae Asset Global Investments’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-15,334
Closed -$918K – 1534
2019
Q4 		$918K Buy
15,334
+2,262
+17% +$84.9K 0.01% 986
2019
Q3 		$367K Buy
+13,072
New +$446K ﹤0.01% 1255

Mirae Asset Global Investments's BOLD Position: Q1 2020 in Review

Mirae Asset Global Investments sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 15,334 shares — an estimated $918K sold.

Mirae Asset Global Investments first reported a position in BOLD in Q3 2019 and held it in 2 quarters. The position peaked at $918K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Mirae Asset Global Investments reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Mirae Asset Global Investments sold 15,334 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $918K.
  • Mirae Asset Global Investments first reported a position in Audentes Therapeutics, Inc in Q3 2019 and held it in 2 quarters.
  • Mirae Asset Global Investments's Audentes Therapeutics, Inc position peaked at $918K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Mirae Asset Global Investments's 13F filing for Q1 2020, filed 12 May 2020.